22.418 articles found

Stem cells for the treatment of neurological disorders.

Lindvall O, Kokaia Z.

Nature · 2006-06-01

DOI: 10.1038/nature04960PMID: 16810245

[Valvular heart disease associated with the treatment of Parkinson disease].

Rasmussen VG, Dupont E, Østergaard K, Egeblad H.

Ugeskr Laeger · 2006-06-01

PMID: 16824407

After the diagnosis: living with Parkinson's. There's no cure for Parkinson's disease, but new treatments can ease the symptoms and prolong independence.

Check source for author details

Harv Womens Health Watch · 2006-06-01

PMID: 16841381

[A patient with HIV encephalopathy presenting with parkinsonism during HAART therapy].

Shimohata T, Takadou Y, Terajima K, Tsukada H, Gejo F, Tanaka K, Nishizawa M.

No To Shinkei · 2006-06-01

PMID: 16856518

[Evaluation of effectiveness of the micrographia's therapy in Parkinson's disease patients].

Jarzebska E.

Pol Merkur Lekarski · 2006-06-01

PMID: 17007269

"Getting physical": the management of neuropsychiatric disorders using novel physical treatments.

Malhi GS, Loo C, Cahill CM, Lagopoulos J, Mitchell P, Sachdev P.

Neuropsychiatr Dis Treat · 2006-06-01

DOI: 10.2147/nedt.2006.2.2.165PMID: 19412461

Treatment of depression in Parkinson's disease.

Menza M, Dobkin RD, Marin H.

Curr Psychiatry Rep · 2006-06-01

DOI: 10.1007/s11920-006-0029-8PMID: 19817075

Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study.

Romigi A, Stanzione P, Marciani MG, Izzi F, Placidi F, Cervellino A, Giacomini P, Brusa L, Grossi K, Pierantozzi M.

J Neural Transm (Vienna) · 2006-06-01

DOI: 10.1007/s00702-006-0490-xPMID: 16736238

Computational analysis of subthalamic nucleus and lenticular fasciculus activation during therapeutic deep brain stimulation.

Miocinovic S, Parent M, Butson CR, Hahn PJ, Russo GS, Vitek JL, McIntyre CC.

J Neurophysiol · 2006-05-31

DOI: 10.1152/jn.00305.2006PMID: 16738214

Delivery of compounds for the treatment of parkinson's through an inhalation route

RABINOWITZ JOSHUA D, ZAFFARONI ALEJANDRO C.

· 2006-05-30

Delivery of compounds for the treatment of parkinson's through an inhalation route

RABINOWITZ JOSHUA D, ZAFFARONI ALEJANDRO C.

· 2006-05-30

Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders.

Amer DA, Irvine GB, El-Agnaf OM.

Exp Brain Res · 2006-05-30

DOI: 10.1007/s00221-006-0539-yPMID: 16733698